Cytiva

Safety and Innovation: Navigating the Challenges of Antibody-Drug Conjugates

This eBook provides scientists with more information on antibody–drug conjugates (ADCs), allowing you to further your research in this field.

Sponsored • Whitepaper • Bioprocessing

How Biotechnological Advances are Transforming Monoclonal Antibody Production

This Article Collection aims to offer scientists a wealth of information on monoclonal antibody (mAb) therapy, enabling you to advance your research in this field.

News

Cytiva Boosts Biomanufacturing with Cevec Buy

US life sciences company Cytiva has acquired Germany’s Cevec Pharmaceuticals, a move Cytiva said would further strengthen its leading position in biomanufacturing solutions. Financial terms were not revealed.

News

Cytiva Invests in US Resins Expansion

Life science company Cytiva has acquired a chromatography resins factory in Muskegon, Michigan, USA, marking its first investment in new capacity outside its manufacturing base of Sweden.

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

INOSIM GmbH

Predictive Simulation in Pharma Production

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Interview

Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Cytiva